WebMar 1, 2024 · European companies like Compass Pathways, Beckley Psytech and Atai Life Sciences are leading the race to dominate the new psychedelic market. By Sian Bradley 1 March 2024. Through most of the 20th century, the piobneering research in the use of psychedelics to treat mental health disorders has largely come out of the US. WebATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2024 and is headquartered in Berlin, Germany.

ATAI IPO: Peter Thiel-backed psychedelics firm to raise $100 million - CNBC

WebDec 16, 2024 · atai is a biotechnology company founded in 2024 in response to the clear and growing unmet needs of mental health patients worldwide. atai is dedicated to acquiring, incubating and efficiently ... WebAtai invests in companies developing mental health treatments, often with a majority interest or an option to get one. It oversees 10 therapeutic programs handled by such companies. semo signs and graphics

Dr Andreas Cebulla Researcher Profiles - University of Adelaide

WebMar 3, 2024 · Atai Life Sciences AG, a German startup looking into ways of using psychedelic substances to treat mental-health disorders, has been valued at about $2 billion in a funding round ahead of its ... WebMar 16, 2024 · Andy Cebulla is a Global Corporate Controller at Donaldson Company based in Bloomington, Minnesota. Previously, Andy was a Chief Accounting Office r & Vice President & Corporate Controller at APi Group and also held positions at Tennant, MTS Systems, Ceridian, Emerson, Honeywell, Honeywell, Deloitte. Andy received a Bachelor … http://www.hno-buedingen.de/ semo shuttle tracker